CT-080: A Tumor-Agnostic TCR-Mimic CAR-T cell Specific for NDC80 Targets Multiple Hematological Malignancies

MLA

Tanya Korontsvit, et al. “CT-080: A Tumor-Agnostic TCR-Mimic CAR-T Cell Specific for NDC80 Targets Multiple Hematological Malignancies.” Clinical Lymphoma Myeloma and Leukemia, vol. 21, Sept. 2021, pp. S447–48. EBSCOhost, https://doi.org/10.1016/s2152-2650(21)01994-7.

APA

Tanya Korontsvit, Michael G. Kharas, Martin G. Klatt, Megan M. Dacek, David A. Scheinberg, Hanzhi Luo, Zita E.H. Aretz, Christopher M. Bourne, Tao Dao, Thomas J. Gardner, Cheng Liu, Leila Peraro, Zhiyuan Yang, Sung Soo Mun, & Jianying Liu. (2021). CT-080: A Tumor-Agnostic TCR-Mimic CAR-T cell Specific for NDC80 Targets Multiple Hematological Malignancies. Clinical Lymphoma Myeloma and Leukemia, 21, S447–S448. https://doi.org/10.1016/s2152-2650(21)01994-7

Chicago

Tanya Korontsvit, Michael G. Kharas, Martin G. Klatt, Megan M. Dacek, David A. Scheinberg, Hanzhi Luo, Zita E.H. Aretz, et al. 2021. “CT-080: A Tumor-Agnostic TCR-Mimic CAR-T Cell Specific for NDC80 Targets Multiple Hematological Malignancies.” Clinical Lymphoma Myeloma and Leukemia 21 (September): S447–48. doi:10.1016/s2152-2650(21)01994-7.